{"id":31209,"date":"2025-09-23T10:44:39","date_gmt":"2025-09-23T10:44:39","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/es\/?post_type=portfolio-products&#038;p=31209"},"modified":"2026-03-25T10:52:00","modified_gmt":"2026-03-25T10:52:00","slug":"%e2%96%bcbriumvi","status":"publish","type":"portfolio-products","link":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi","title":{"rendered":"\u25bcBriumvi \u00ae"},"content":{"rendered":"<p>Briumvi \u00ae est\u00e1 indicado para el tratamiento de pacientes adultos con formas recurrentes de esclerosis m\u00faltiple (EMR) con enfermedad activa definida por caracter\u00edsticas cl\u00ednicas o de imagen.<\/p>\n<p>\u25bcEste medicamento est\u00e1 sujeto a seguimiento adicional, es prioritaria la notificaci\u00f3n de sospechas de reacciones adversas asociadas a este medicamento. Consulte la ficha t\u00e9cnica completa antes de prescribir el medicamento.<\/p>\n","protected":false},"featured_media":31545,"parent":0,"template":"","product-category":[231],"therapeutic-area":[370],"active-substance":[369],"class_list":["post-31209","portfolio-products","type-portfolio-products","status-publish","has-post-thumbnail","hentry","product-category-hospitales","therapeutic-area-esclerosis-multiple","active-substance-ublituximab"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u25bcBriumvi \u00ae - Neuraxpharm Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/\u25bcbriumvi\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u25bcBriumvi \u00ae\" \/>\n<meta property=\"og:description\" content=\"Briumvi \u00ae est\u00e1 indicado para el tratamiento de pacientes adultos con formas recurrentes de esclerosis m\u00faltiple (EMR) con enfermedad activa definida por caracter\u00edsticas cl\u00ednicas o de imagen. \u25bcEste medicamento est\u00e1 sujeto a seguimiento adicional, es prioritaria la notificaci\u00f3n de sospechas de reacciones adversas asociadas a este medicamento. Consulte la ficha t\u00e9cnica completa antes de prescribir [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/\u25bcbriumvi\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Espa\u00f1a\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-25T10:52:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi\",\"name\":\"\u25bcBriumvi \u00ae - Neuraxpharm Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png\",\"datePublished\":\"2025-09-23T10:44:39+00:00\",\"dateModified\":\"2026-03-25T10:52:00+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png\",\"width\":700,\"height\":700},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/\",\"name\":\"Neuraxpharm Espa\u00f1a\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u25bcBriumvi \u00ae - Neuraxpharm Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/\u25bcbriumvi","og_locale":"es_ES","og_type":"article","og_title":"\u25bcBriumvi \u00ae","og_description":"Briumvi \u00ae est\u00e1 indicado para el tratamiento de pacientes adultos con formas recurrentes de esclerosis m\u00faltiple (EMR) con enfermedad activa definida por caracter\u00edsticas cl\u00ednicas o de imagen. \u25bcEste medicamento est\u00e1 sujeto a seguimiento adicional, es prioritaria la notificaci\u00f3n de sospechas de reacciones adversas asociadas a este medicamento. Consulte la ficha t\u00e9cnica completa antes de prescribir [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/\u25bcbriumvi","og_site_name":"Neuraxpharm Espa\u00f1a","article_modified_time":"2026-03-25T10:52:00+00:00","og_image":[{"width":700,"height":700,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi","url":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi","name":"\u25bcBriumvi \u00ae - Neuraxpharm Espa\u00f1a","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png","datePublished":"2025-09-23T10:44:39+00:00","dateModified":"2026-03-25T10:52:00+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/%e2%96%bcbriumvi#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/22102827\/briumvi.png","width":700,"height":700},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/es\/#website","url":"https:\/\/www.neuraxpharm.com\/es\/","name":"Neuraxpharm Espa\u00f1a","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/31209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/types\/portfolio-products"}],"version-history":[{"count":15,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/31209\/revisions"}],"predecessor-version":[{"id":33287,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/31209\/revisions\/33287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media\/31545"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media?parent=31209"}],"wp:term":[{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/product-category?post=31209"},{"taxonomy":"therapeutic-area","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/therapeutic-area?post=31209"},{"taxonomy":"active-substance","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/active-substance?post=31209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}